USPTO serial 79171690
P OXFORD PHARMAGENESIS THE HEALTHSCIENCE COMMUNICATORS
Reviewed by CopyMark Law Group
Reg. 5515951Status 739Registered
- Filing date
- Status date
- Registration date
- Jul 17, 2018
- Examiner
- BROWN, BARBARA TROFFKIN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with P OXFORD PHARMAGENESIS THE HEALTHSCIENCE COMMUNICATORS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Katherine K. Madianos
Katherine K. Madianos Pirkey Barber PLLC1801 East 6th Street, Suite 300Austin, TX 78702United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic publications in the nature of peer-reviewed journals in the healthcare, pharmaceutical and scientific field; Downloadable e-books in the healthcare, pharmaceutical, and scientific field; audio recordings featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; video recordings featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable MP3 featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine.; Software that functions to make accessible to, inform, and educate clients on peer-reviewed health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; application Software that functions to make accessible to, inform, and educate clients on peer-reviewed health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; educational Software that functions to make accessible to, inform, and educate clients on peer-reviewed health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable databases featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable electronic databases featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Downloadable computer databases featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Optical compact discs featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; blank magnetic discs, blank optical discs, blank data cassettes, and blank magnetic computer tapes, all featuring the ability to record, store, and transmit sound, video, images, and data in the healthcare, pharmaceutical, and scientific field; all for others, and all in the healthcare, pharmaceutical and scientific field | ACTIVE | — |
| 016 | Printed matter and printed publications, namely, brochures and booklets in the healthcare, pharmaceutical, and scientific field; Books in the healthcare, pharmaceutical, and scientific field; Magazines in the healthcare, pharmaceutical, and scientific field; Newsletters in the healthcare, pharmaceutical, and scientific field; Journals in the healthcare, pharmaceutical, and scientific field; Printed periodicals in the healthcare, pharmaceutical, and scientific field; almanacs; diaries; calendars; advertising publicity and promotional materials, namely, pamphlets, signs, brochures, leaflets, or informational sheets about the healthcare, pharmaceutical, and scientific field; Manuals featuring peer-reviewed educational health science evidence and information on all major therapeutic areas including immunology, hematology, psychiatry, neuroscience, ophthalmology, rheumatology, oncology, nephrology, gastroenterology, metabolic diseases, endocrinology, cardiology, reproductive health, and respiratory medicine; Event programs in the healthcare, pharmaceutical, and scientific field; Booklets about healthcare, pharmaceutical, and scientific field; Pamphlets in the healthcare, pharmaceutical, and scientific field; Leaflets in the healthcare, pharmaceutical, and scientific field; Informational flyers in the healthcare, pharmaceutical, and scientific field; Brochures in the healthcare, pharmaceutical, and scientific field; Catalogues in the healthcare, pharmaceutical, and scientific field; information sheets in the nature of printed booklets in the healthcare, pharmaceutical, and scientific field; scrapbooks; notebooks; photographs; photographic prints; pictures; illustrations; printed images, namely, comics; posters; printed educational instructional training and teaching materials in the healthcare, pharmaceutical, and scientific field;, not including apparatus; stationery and educational supplies, namely, note books; artists' materials and writing materials, namely, pencils; writing instruments; paper; stationery cards; greeting cards; Christmas cards; all in the healthcare, pharmaceutical and scientific field | ACTIVE | — |
| 035 | Advertising marketing and promotional services; development of marketing strategies and concepts; Operational business assistance to enterprises for others in the pharmaceutical field; business management consulting in relation to marketing production, sales; business planning and strategy development services; business risk management services; Providing business information in the pharmaceutical field; Providing information in the field of economics; Provision of market research information; analysis of market research data and statistics featuring the issuance of reports; public relations services; advertising and publicity services in the nature of product launch services; business consultation and management regarding launching of new products; business advisory services relating to product development and the exploitation of inventions; brand consultancy services in the nature of Brand imagery consulting; advertising and promotion services, namely, brand creation services; creating advertising material; placing advertisements for others; developing promotional campaigns for business; business evaluation of business expansion opportunities for others; publication of publicity texts and materials; all the aforesaid services in the field of pharmaceuticals only | ACTIVE | — |
| 041 | Education services, namely, providing live and on-line seminars, workshops, and courses in the healthcare, pharmaceutical and scientific field; provision of training and mentoring for the continuing education of pharmaceutical companies, healthcare organizations, medical device companies, diagnostics companies, nutraceuticals companies, professional societies, patient groups, and academic institutions in the healthcare, pharmaceutical and scientific field; Education services, namely, arranging, organizing, and conducting courses, lectures, seminars, and workshops for educational purposes in the healthcare, pharmaceutical and scientific field; Education services, namely, arranging, organizing, and conducting of conventions, congresses, conferences, and exhibitions for educational purposes, all in the healthcare, pharmaceutical and scientific field; arranging, organizing, and conducting educational and entertainment competitions in the healthcare, pharmaceutical and scientific field for others; Providing continuing business education courses in the healthcare, pharmaceutical and scientific field; computer based training for the continuing education of pharmaceutical companies, healthcare organizations, specialist devices companies, diagnostics companies, nutraceuticals companies, professional societies, patient groups, and academic institutions in the healthcare, pharmaceutical and scientific field; provision of training courses for the continuing education of pharmaceutical companies, healthcare organizations, medical device companies, diagnostics companies, nutraceuticals companies, professional societies, patient groups, and academic institutions in the healthcare, pharmaceutical and scientific field; provision of training courses in strategic planning relating to advertising promotion, marketing, all in the healthcare, pharmaceutical and scientific field; Providing news in the nature of current event reporting; Publishing of electronic publications for others; publication of printed matter not for advertising or publicity purposes, namely, printed publications, texts, books, magazines, newsletters, journals, periodicals, almanacs, diaries, calendars, manuals, programs, booklets, pamphlets, leaflets, flyers, brochures, catalogues, information sheets, scrapbooks, notebooks, photographs, photographic prints, pictures, illustrations, printed images, posters, and instructional, training, and teaching printed materials all in the healthcare, pharmaceutical, and scientific field | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford PharmaGenesis Limited
- Other trademarks owned by Oxford PharmaGenesis Limited
- Other trademarks owned by Oxford PharmaGenesis Limited
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Similar marks named P OXFORD PHARMAGENESIS THE HEALTHSCIENCE COMMUNICATORS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 22, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 22, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 22, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Sep 22, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 22, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 22, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 9, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 9, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 9, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 3, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Feb 3, 2025 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jan 27, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 31, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 16, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 31, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 19, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 19, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 19, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 19, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 19, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 17, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 16, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 29, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 29, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 17, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 17, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2018 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jun 11, 2018 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jun 11, 2018 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Feb 24, 2017 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 8, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2017 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 30, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2016 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 1, 2016 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jul 28, 2016 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Jul 28, 2016 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Apr 29, 2016 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 29, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 29, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 9, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 9, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 17, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 22, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 24, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 24, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 24, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 3, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 3, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 2, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 15, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 15, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 15, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 14, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2015 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Sep 13, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 12, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 4, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |